Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
06/2012
06/12/2012US8198258 Oligoribonucleotides and methods of use thereof for treatment of fibrotic conditions and other diseases
06/12/2012US8198081 Dopaminergic neuron progenitor cell marker 187A5
06/12/2012US8198048 Mammalian sweet taste receptors
06/12/2012US8198031 Detecting and profiling molecular complexes
06/12/2012US8197819 Exposure of epitopes on envelop protein; complex of polypeptide and antigen; induce immunology response
06/12/2012US8197815 Anti-EphrinB2 antibodies and methods using same
06/12/2012US8197814 Method for treating the Th2-mediated disease
06/12/2012US8197813 Human antibodies that bind human TNFα
06/12/2012US8197812 IL-1-like cytokine antibodies
06/12/2012US8197811 Methods of use of sialoadhesin factor-2 antibodies
06/12/2012US8197810 Binding domain-immunoglobulin fusion proteins
06/12/2012US8197809 CD9-specific human antibodies
06/12/2012US8197430 Method and system to remove cytokine inhibitor in patients
06/12/2012CA2502385C Il-1 receptor based antagonists and methods of making and using
06/12/2012CA2288992C Single-chain antigen-binding proteins capable of glycosylation, production and uses thereof
06/12/2012CA2262756C A tumor necrosis factor related ligand
06/12/2012CA2249746C Porphyromonas gingivalis antigens for the diagnosis and treatment of periodontitis
06/12/2012CA2214830C Nucleotide and protein sequences of vertebrate serrate genes and methods based thereon
06/12/2012CA2180473C Cloning and characterization of h.pylori flba gene. production of aflagellate strains
06/12/2012CA1341631C Nucleic acid encoding the alpha or beta chains of inhibin and method forsynthesizing polypeptides using such nucleic acid
06/07/2012WO2012075361A2 In vivo copper-free click chemistry for delivery of therapeutic and/or diagnostic agents
06/07/2012WO2012075342A2 Anti-bradykinin b2 receptor (bkb2r) monoclonal antibody
06/07/2012WO2012075340A2 Anti-ngf compositions and use thereof
06/07/2012WO2012075333A2 Her2delta16 peptides
06/07/2012WO2012075238A1 Novel receptor-ligand interaction and uses thereof
06/07/2012WO2012075158A1 Chimeric rabbit/human ror1 antibodies
06/07/2012WO2012075111A1 Uses of anti-cd40 antibodies in combination therapy for b cell-related cancers
06/07/2012WO2012075037A1 Low affinity blood brain barrier receptor antibodies and uses therefor
06/07/2012WO2012075023A2 Neoantibodies for diagnosing tissue injury
06/07/2012WO2012074097A1 Anti-cd33 antibody
06/07/2012WO2012074029A1 Polynucleotide construct capable of presenting fab in acellular translation system, and method for manufacturing and screening fab using same
06/07/2012WO2012073992A1 Antigen-binding molecule capable of binding to plurality of antigen molecules repeatedly
06/07/2012WO2012073985A1 Cytotoxicity-inducing therapeutic agent
06/07/2012WO2012073459A1 Tomm34 peptides and vaccines including the same
06/07/2012WO2012072820A1 Methods and pharmaceutical compositions for the treatment of heart failure
06/07/2012WO2012072814A1 Means and methods for producing high affinity antibodies
06/07/2012WO2012072788A1 Vaccine against influenza h5n1 viruses, medicament and treatment of h5n1 viral infections
06/07/2012WO2012072731A2 Improved anti-serum albumin binding single variable domains
06/07/2012WO2012072611A1 SYNTHETIC LIGANDS FOR HUMAN ANTI-Aβ ANTIBODIES
06/07/2012WO2012072268A2 Tolerance induction or immunosupression to prevent in particular graft-versus-host-disease (gvhd) by short-term pre-incubation of transplanted cell suspensions, tissues or organs coated with ligands to cell surface molecules
06/07/2012WO2012071649A1 Covalently dimerized bivalent binding agents
06/07/2012WO2012040518A3 Carrier immunoglobulins and uses thereof
06/07/2012WO2012031099A3 Anti-cxcl13 antibodies and methods of using the same
06/07/2012WO2012009774A3 Recombinant microorganisms, methods for preparing vaccine strains, antigens, and vector vaccine compositions of same, uses thereof, and related antibodies, diagnostic kit, and treatment and/or prophylactic methods
06/07/2012WO2011163458A3 Compositions and methods containing alkylgycosides for stabilizing protein- containing formulations
06/07/2012WO2011061944A8 Fluoroimmunoassay method
06/07/2012US20120142903 Methods For Detecting And Analyzing N-Glycolylneuraminic Acid (NEU5GC) In Biological Materials
06/07/2012US20120142902 Prevention and Treatment of Synucleinopathic and Amyloidogenic Disease
06/07/2012US20120142901 Purification method which prevents denaturation of an antibody
06/07/2012US20120142900 Antibodies to il-6 and use thereof
06/07/2012US20120142899 Novel anti-notch3 antibodies and their use in the detection and diagnosis of disease
06/07/2012US20120142607 Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
06/07/2012US20120142548 Methods and compositions for the diagnosis and prognosis of alzheimer's disease
06/07/2012US20120142098 Fc receptor-binding polypeptides with modified effector functions
06/07/2012US20120142054 Srsv detection kit
06/07/2012US20120142048 Nucleic acid which is stabilized against decomposition
06/07/2012US20120142029 Nucleic acids encoding a g-protein coupled receptor involved in sensory transduction
06/07/2012US20120141538 Modulators of the cx3cri receptor and therapeutic uses thereof
06/07/2012US20120141530 Canine lyme disease vaccine
06/07/2012US20120141527 Structured viral peptide compositions and methods of use
06/07/2012US20120141522 Recombinant protective protein from streptococcus pneumoniae
06/07/2012US20120141519 Reagents and methods for detecting influenza virus proteins
06/07/2012US20120141518 Human Parvovirus: Bocavirus
06/07/2012US20120141510 Monomethylvaline compounds capable of conjugation to ligands
06/07/2012US20120141509 Monomethylvaline compounds capable of conjugation to ligands
06/07/2012US20120141508 Monomethylvaline compounds capable of conjugation to ligands
06/07/2012US20120141505 Cd19-ligand and use
06/07/2012US20120141503 Heavy Chain and Domain Antibodies
06/07/2012US20120141501 Pharmaceutical Composition Containing Antagonist of EGF Family Ligand as Component
06/07/2012US20120141500 Antibodies Against Human Angiopoietin 2
06/07/2012US20120141499 Specific binding agents of human angiopoietin-2
06/07/2012US20120141497 Methods of purifying small modular immunopharmaceutical proteins
06/07/2012US20120141495 Method for suppressing tumor growth by blocking fibroblast growth factor receptor, and method for diagnosing malignant neoplasms
06/07/2012US20120141494 Fully human antibodies against human 4-1bb
06/07/2012US20120141493 Human binding molecules having killing activity against staphylococci and uses thereof
06/07/2012US20120141492 Anti-il 17a /il-17f cross-reactive antibodies and methods of use thereof
06/07/2012US20120141490 Antibodies That Bind Selectively To P25 And Uses Therefor
06/07/2012US20120141487 Moraxella catarrhalis antigens
06/07/2012US20120141486 Human monoclonal antibody
06/07/2012US20120141481 Wnt antagonists and their use in the diagnosis and treatment of wnt-mediated disorders
06/07/2012US20120141480 Methods of treating with anti-factor d antibodies
06/07/2012US20120141478 Compositions and methods for delivering anti-activated ras antibodies
06/07/2012US20120141477 Antibodies That Specifically Bind to ABeta Oligomers and Uses Thereof
06/07/2012US20120141476 FcGammaRIIB Specific Antibodies and Methods of Use Thereof
06/07/2012US20120141475 TNF-alpha Antagonists and Methotrexate in the Treatment of TNF-Mediated Disease
06/07/2012US20120141474 TNF-alpha Antagonists and Methotrexate in the Treatment of TNF-Mediated Disease
06/07/2012US20120141471 Methods of Inhibiting Metastasis from Cancer
06/07/2012US20120141470 T cell inhibitory receptor compositions and uses thereof
06/07/2012US20120141469 Cripto antagonism of activin and tgf-b signaling
06/07/2012US20120141464 Binding member for gm-csf receptor
06/07/2012US20120141463 Method Of Identifying Membrane Ig Specific Antibodies And Use Thereof For Targeting Immunoglobulin-Producing Precursor Cells
06/07/2012US20120141462 Methods and compositions for diagnosis and treatment of b cell chronic lymphocytic leukemia
06/07/2012US20120141460 Method for the production of variable domains
06/07/2012US20120141456 Use of DR6 and p75 Antagonists to Promote Survival of Cells of the Nervous System
06/07/2012US20120141451 Fibroblast growth factor receptor-derived peptides binding to ncam
06/07/2012US20120141449 Albumin Fusion Proteins
06/07/2012US20120141415 Albumin Fusion Proteins
06/07/2012US20120141411 Uses of IL-174 Antagonists for Inhibiting A Th2 Immune Response
06/07/2012US20120141376 Prostate specific transcripts and the use thereof for prostate cancer therapeutics and diagnostics
06/07/2012US20120141373 Antibodies and Methods of Use Thereof